Feb 20, 2020
VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update
Jan 10, 2020
VolitionRx Completes Acquisition of Octamer GmbH
Dec 19, 2019
Volition Capital Announces Closing of $600 Million in Two Oversubscribed Funds: Volition Capital Fund IV, L.P. and Volition Capital Select Fund I, L.P.
Nov 12, 2019
VolitionRx Limited Announces Third Quarter 2019 Financial Results and Business Update
Oct 25, 2019
Texas A&M University Takes A 12.5% Equity Stake in Volition Veterinary Diagnostics Development LLC
Oct 18, 2019
Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas
Aug 12, 2019
VolitionRx Limited Announces Second Quarter 2019 Financial Results and Business Update
Aug 08, 2019
Volition Forms Texas-Based Veterinary Subsidiary and Appoints its Chief Executive Officer
Jul 24, 2019
Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock
Jul 10, 2019
VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding
Apr 09, 2019
VolitionRx Limited Hosts Capital Markets Day at the New York Stock Exchange and Issues Company Update Report
Apr 09, 2019
VolitionRx Limited Signs Memorandum of Understanding with Texas A&M University for Potential Collaboration to Develop Nu.QTM Veterinary Diagnostics
Mar 15, 2019
VolitionRx Limited to Present at Conferences in the U.S. Next Week
Oct 04, 2018
VolitionRx Limited to Expand its Nu.Q(TM) Trials to Veterinary Diagnostics
Aug 01, 2018
VolitionRx's First Research Use Only Product Is "On-The-Shelf" Today
Jul 02, 2018
Volition Secures Additional $700,000 Non-Dilutive Funding from the Walloon Region
Mar 07, 2018
VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board
Sep 21, 2017
VolitionRx Limited Awarded $1.5 Million in Non-Dilutive Funding
Aug 03, 2017
VolitionRx Limited Schedules Second Quarter 2017 Earnings Conference Call and Business Update
Jun 27, 2017
VolitionRx Limited Corrects an Earlier Announcement